Cash Flow EC Healthcare Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
-418.00
-5.00
11.00
123.00
322.00
260.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
70.00
119.00
-47.00
-168.00
-134.00
80.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
592.00
706.00
645.00
608.00
603.00
616.00
Cash Flow from Investing Activities
-300.00
292.00
-512.00
-715.00
-586.00
-366.00
Cash Flow from Financing Activities
-531.00
-548.00
-289.00
-51.00
-80.00
158.00
Net Cash Inflow / Outflow
-236.00
450.00
-156.00
-160.00
-60.00
410.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
2.00
0.00
0.00
-1.00
1.00
2.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of EC Healthcare
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-418.662
21.1742342899885
-439.00
-2077.22%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
70.128
5.59830963967019
65.00
1152.66%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
592.237
56.4310045488104
536.00
949.49%
Cash Flow from Investing Activities
-300.793
14.1519454645595
-314.00
-2225.45%
Cash Flow from Financing Activities
-531.18
-11.2248168869792
-520.00
-4632.19%
Net Cash Inflow / Outflow
-236.976
55.099209849563
-291.00
-530.09%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
2.76
-4.25892327682775
6.00
164.81%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is -16.14% vs 9.34% in Mar 2025
Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
592.24
706.21
-16.14%
Footer loading
